Industry: Medical Devices & Consumables
Published Date: 2025-06-28
Pages: 122 Pages
Report ld: 4776788
Request Sample
Customized Report
Intravenous Injection Training Model Market Size(US$)

CAGR 2025-2031
6.9%
Market Size,2031
USD 975
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Intravenous Injection Training Model market size was US$ 611 million in 2024 and is forecast to a readjusted size of US$ 975 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Intravenous Injection Training Model market competitiveness, regional economic performance, and supply chain configurations.
The Intravenous Injection Training Model is a human simulation model designed for medical students, nurses, and healthcare professionals to practice intravenous injection techniques, improving operational safety and accuracy.
The North America Intravenous Injection Training Model market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Intravenous Injection Training Model include 3B Scientific, Laerdal Medical, CAE Healthcare, Simulab Corporation, Limbs & Things, KOKEN, Gaumard Scientific, Nasco Healthcare, Kyoto Kagaku, Realityworks, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Intravenous Injection Training Model market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Intravenous Injection Training Model market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Infant Intravenous Injection Models in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Hospital Nursing Training in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Intravenous Injection Training Model value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Intravenous Injection Training Model Product Scope
1.2 Intravenous Injection Training Model by Type
1.2.1 Global Intravenous Injection Training Model Sales by Type (2020 & 2024 & 2031)
1.2.2 Adult Intravenous Injection Models
1.2.3 Infant Intravenous Injection Models
1.3 Intravenous Injection Training Model by Application
1.3.1 Global Intravenous Injection Training Model Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Medical School Training
1.3.3 Hospital Nursing Training
1.3.4 Clinical Skills Assessment
1.3.5 Simulation-based Research
1.3.6 Others
1.4 Global Intravenous Injection Training Model Market Estimates and Forecasts (2020-2031)
1.4.1 Global Intravenous Injection Training Model Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Intravenous Injection Training Model Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Intravenous Injection Training Model Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Intravenous Injection Training Model Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Intravenous Injection Training Model Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Intravenous Injection Training Model Sales Market Share by Region (2020-2025)
2.2.2 Global Intravenous Injection Training Model Revenue Market Share by Region (2020-2025)
2.3 Global Intravenous Injection Training Model Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Intravenous Injection Training Model Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Intravenous Injection Training Model Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Intravenous Injection Training Model Market Size and Prospective (2020-2031)
2.4.2 Europe Intravenous Injection Training Model Market Size and Prospective (2020-2031)
2.4.3 China Intravenous Injection Training Model Market Size and Prospective (2020-2031)
2.4.4 Japan Intravenous Injection Training Model Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Intravenous Injection Training Model Historic Market Review by Type (2020-2025)
3.1.1 Global Intravenous Injection Training Model Sales by Type (2020-2025)
3.1.2 Global Intravenous Injection Training Model Revenue by Type (2020-2025)
3.1.3 Global Intravenous Injection Training Model Price by Type (2020-2025)
3.2 Global Intravenous Injection Training Model Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Intravenous Injection Training Model Sales Forecast by Type (2026-2031)
3.2.2 Global Intravenous Injection Training Model Revenue Forecast by Type (2026-2031)
3.2.3 Global Intravenous Injection Training Model Price Forecast by Type (2026-2031)
3.3 Different Types Intravenous Injection Training Model Representative Players
4 Global Market Size by Application
4.1 Global Intravenous Injection Training Model Historic Market Review by Application (2020-2025)
4.1.1 Global Intravenous Injection Training Model Sales by Application (2020-2025)
4.1.2 Global Intravenous Injection Training Model Revenue by Application (2020-2025)
4.1.3 Global Intravenous Injection Training Model Price by Application (2020-2025)
4.2 Global Intravenous Injection Training Model Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Intravenous Injection Training Model Sales Forecast by Application (2026-2031)
4.2.2 Global Intravenous Injection Training Model Revenue Forecast by Application (2026-2031)
4.2.3 Global Intravenous Injection Training Model Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Intravenous Injection Training Model Application
5 Competition Landscape by Players
5.1 Global Intravenous Injection Training Model Sales by Players (2020-2025)
5.2 Global Top Intravenous Injection Training Model Players by Revenue (2020-2025)
5.3 Global Intravenous Injection Training Model Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Injection Training Model as of 2024)
5.4 Global Intravenous Injection Training Model Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Intravenous Injection Training Model, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Intravenous Injection Training Model, Product Type & Application
5.7 Global Key Manufacturers of Intravenous Injection Training Model, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Intravenous Injection Training Model Sales by Company
6.1.1.1 North America Intravenous Injection Training Model Sales by Company (2020-2025)
6.1.1.2 North America Intravenous Injection Training Model Revenue by Company (2020-2025)
6.1.2 North America Intravenous Injection Training Model Sales Breakdown by Type (2020-2025)
6.1.3 North America Intravenous Injection Training Model Sales Breakdown by Application (2020-2025)
6.1.4 North America Intravenous Injection Training Model Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Intravenous Injection Training Model Sales by Company
6.2.1.1 Europe Intravenous Injection Training Model Sales by Company (2020-2025)
6.2.1.2 Europe Intravenous Injection Training Model Revenue by Company (2020-2025)
6.2.2 Europe Intravenous Injection Training Model Sales Breakdown by Type (2020-2025)
6.2.3 Europe Intravenous Injection Training Model Sales Breakdown by Application (2020-2025)
6.2.4 Europe Intravenous Injection Training Model Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Intravenous Injection Training Model Sales by Company
6.3.1.1 China Intravenous Injection Training Model Sales by Company (2020-2025)
6.3.1.2 China Intravenous Injection Training Model Revenue by Company (2020-2025)
6.3.2 China Intravenous Injection Training Model Sales Breakdown by Type (2020-2025)
6.3.3 China Intravenous Injection Training Model Sales Breakdown by Application (2020-2025)
6.3.4 China Intravenous Injection Training Model Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Intravenous Injection Training Model Sales by Company
6.4.1.1 Japan Intravenous Injection Training Model Sales by Company (2020-2025)
6.4.1.2 Japan Intravenous Injection Training Model Revenue by Company (2020-2025)
6.4.2 Japan Intravenous Injection Training Model Sales Breakdown by Type (2020-2025)
6.4.3 Japan Intravenous Injection Training Model Sales Breakdown by Application (2020-2025)
6.4.4 Japan Intravenous Injection Training Model Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 3B Scientific
7.1.1 3B Scientific Company Information
7.1.2 3B Scientific Business Overview
7.1.3 3B Scientific Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.1.4 3B Scientific Intravenous Injection Training Model Products Offered
7.1.5 3B Scientific Recent Development
7.2 Laerdal Medical
7.2.1 Laerdal Medical Company Information
7.2.2 Laerdal Medical Business Overview
7.2.3 Laerdal Medical Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Laerdal Medical Intravenous Injection Training Model Products Offered
7.2.5 Laerdal Medical Recent Development
7.3 CAE Healthcare
7.3.1 CAE Healthcare Company Information
7.3.2 CAE Healthcare Business Overview
7.3.3 CAE Healthcare Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.3.4 CAE Healthcare Intravenous Injection Training Model Products Offered
7.3.5 CAE Healthcare Recent Development
7.4 Simulab Corporation
7.4.1 Simulab Corporation Company Information
7.4.2 Simulab Corporation Business Overview
7.4.3 Simulab Corporation Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Simulab Corporation Intravenous Injection Training Model Products Offered
7.4.5 Simulab Corporation Recent Development
7.5 Limbs & Things
7.5.1 Limbs & Things Company Information
7.5.2 Limbs & Things Business Overview
7.5.3 Limbs & Things Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Limbs & Things Intravenous Injection Training Model Products Offered
7.5.5 Limbs & Things Recent Development
7.6 KOKEN
7.6.1 KOKEN Company Information
7.6.2 KOKEN Business Overview
7.6.3 KOKEN Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.6.4 KOKEN Intravenous Injection Training Model Products Offered
7.6.5 KOKEN Recent Development
7.7 Gaumard Scientific
7.7.1 Gaumard Scientific Company Information
7.7.2 Gaumard Scientific Business Overview
7.7.3 Gaumard Scientific Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Gaumard Scientific Intravenous Injection Training Model Products Offered
7.7.5 Gaumard Scientific Recent Development
7.8 Nasco Healthcare
7.8.1 Nasco Healthcare Company Information
7.8.2 Nasco Healthcare Business Overview
7.8.3 Nasco Healthcare Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Nasco Healthcare Intravenous Injection Training Model Products Offered
7.8.5 Nasco Healthcare Recent Development
7.9 Kyoto Kagaku
7.9.1 Kyoto Kagaku Company Information
7.9.2 Kyoto Kagaku Business Overview
7.9.3 Kyoto Kagaku Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Kyoto Kagaku Intravenous Injection Training Model Products Offered
7.9.5 Kyoto Kagaku Recent Development
7.10 Realityworks
7.10.1 Realityworks Company Information
7.10.2 Realityworks Business Overview
7.10.3 Realityworks Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Realityworks Intravenous Injection Training Model Products Offered
7.10.5 Realityworks Recent Development
7.11 Anatomage
7.11.1 Anatomage Company Information
7.11.2 Anatomage Business Overview
7.11.3 Anatomage Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Anatomage Intravenous Injection Training Model Products Offered
7.11.5 Anatomage Recent Development
7.12 Adam Rouilly
7.12.1 Adam Rouilly Company Information
7.12.2 Adam Rouilly Business Overview
7.12.3 Adam Rouilly Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Adam Rouilly Intravenous Injection Training Model Products Offered
7.12.5 Adam Rouilly Recent Development
7.13 Altay Scientific
7.13.1 Altay Scientific Company Information
7.13.2 Altay Scientific Business Overview
7.13.3 Altay Scientific Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Altay Scientific Intravenous Injection Training Model Products Offered
7.13.5 Altay Scientific Recent Development
7.14 Shanghai Honglian Medical Tech Group
7.14.1 Shanghai Honglian Medical Tech Group Company Information
7.14.2 Shanghai Honglian Medical Tech Group Business Overview
7.14.3 Shanghai Honglian Medical Tech Group Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Shanghai Honglian Medical Tech Group Intravenous Injection Training Model Products Offered
7.14.5 Shanghai Honglian Medical Tech Group Recent Development
7.15 Yilian Simulation
7.15.1 Yilian Simulation Company Information
7.15.2 Yilian Simulation Business Overview
7.15.3 Yilian Simulation Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Yilian Simulation Intravenous Injection Training Model Products Offered
7.15.5 Yilian Simulation Recent Development
7.16 YUAN Technology Limited
7.16.1 YUAN Technology Limited Company Information
7.16.2 YUAN Technology Limited Business Overview
7.16.3 YUAN Technology Limited Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.16.4 YUAN Technology Limited Intravenous Injection Training Model Products Offered
7.16.5 YUAN Technology Limited Recent Development
7.17 Zhonghui Medical
7.17.1 Zhonghui Medical Company Information
7.17.2 Zhonghui Medical Business Overview
7.17.3 Zhonghui Medical Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.17.4 Zhonghui Medical Intravenous Injection Training Model Products Offered
7.17.5 Zhonghui Medical Recent Development
7.18 Tech Model
7.18.1 Tech Model Company Information
7.18.2 Tech Model Business Overview
7.18.3 Tech Model Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.18.4 Tech Model Intravenous Injection Training Model Products Offered
7.18.5 Tech Model Recent Development
7.19 BIOBASE
7.19.1 BIOBASE Company Information
7.19.2 BIOBASE Business Overview
7.19.3 BIOBASE Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.19.4 BIOBASE Intravenous Injection Training Model Products Offered
7.19.5 BIOBASE Recent Development
7.20 Zhongbang Medical
7.20.1 Zhongbang Medical Company Information
7.20.2 Zhongbang Medical Business Overview
7.20.3 Zhongbang Medical Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.20.4 Zhongbang Medical Intravenous Injection Training Model Products Offered
7.20.5 Zhongbang Medical Recent Development
7.21 Xincheng Simulation
7.21.1 Xincheng Simulation Company Information
7.21.2 Xincheng Simulation Business Overview
7.21.3 Xincheng Simulation Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.21.4 Xincheng Simulation Intravenous Injection Training Model Products Offered
7.21.5 Xincheng Simulation Recent Development
7.22 Mentone Educational
7.22.1 Mentone Educational Company Information
7.22.2 Mentone Educational Business Overview
7.22.3 Mentone Educational Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.22.4 Mentone Educational Intravenous Injection Training Model Products Offered
7.22.5 Mentone Educational Recent Development
7.23 Sakamoto Model Corporation
7.23.1 Sakamoto Model Corporation Company Information
7.23.2 Sakamoto Model Corporation Business Overview
7.23.3 Sakamoto Model Corporation Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.23.4 Sakamoto Model Corporation Intravenous Injection Training Model Products Offered
7.23.5 Sakamoto Model Corporation Recent Development
7.24 Trucorp
7.24.1 Trucorp Company Information
7.24.2 Trucorp Business Overview
7.24.3 Trucorp Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.24.4 Trucorp Intravenous Injection Training Model Products Offered
7.24.5 Trucorp Recent Development
7.25 Anatomy Warehouse
7.25.1 Anatomy Warehouse Company Information
7.25.2 Anatomy Warehouse Business Overview
7.25.3 Anatomy Warehouse Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.25.4 Anatomy Warehouse Intravenous Injection Training Model Products Offered
7.25.5 Anatomy Warehouse Recent Development
7.26 MedVision
7.26.1 MedVision Company Information
7.26.2 MedVision Business Overview
7.26.3 MedVision Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.26.4 MedVision Intravenous Injection Training Model Products Offered
7.26.5 MedVision Recent Development
7.27 Erler-Zimmer
7.27.1 Erler-Zimmer Company Information
7.27.2 Erler-Zimmer Business Overview
7.27.3 Erler-Zimmer Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.27.4 Erler-Zimmer Intravenous Injection Training Model Products Offered
7.27.5 Erler-Zimmer Recent Development
7.28 Simulaids
7.28.1 Simulaids Company Information
7.28.2 Simulaids Business Overview
7.28.3 Simulaids Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.28.4 Simulaids Intravenous Injection Training Model Products Offered
7.28.5 Simulaids Recent Development
7.29 GD/TP
7.29.1 GD/TP Company Information
7.29.2 GD/TP Business Overview
7.29.3 GD/TP Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.29.4 GD/TP Intravenous Injection Training Model Products Offered
7.29.5 GD/TP Recent Development
7.30 ZMCK
7.30.1 ZMCK Company Information
7.30.2 ZMCK Business Overview
7.30.3 ZMCK Intravenous Injection Training Model Sales, Revenue and Gross Margin (2020-2025)
7.30.4 ZMCK Intravenous Injection Training Model Products Offered
7.30.5 ZMCK Recent Development
8 Intravenous Injection Training Model Manufacturing Cost Analysis
8.1 Intravenous Injection Training Model Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Intravenous Injection Training Model
8.4 Intravenous Injection Training Model Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Intravenous Injection Training Model Distributors List
9.3 Intravenous Injection Training Model Customers
10 Intravenous Injection Training Model Market Dynamics
10.1 Intravenous Injection Training Model Industry Trends
10.2 Intravenous Injection Training Model Market Drivers
10.3 Intravenous Injection Training Model Market Challenges
10.4 Intravenous Injection Training Model Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Intravenous Injection Training Model market is projected to grow from US$ 653 million in 2025 to US$ 1035 million by 2032, at a CAGR of 6.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-12
Pages: 210
USD 4900.00
(Single User License)
The global Intravenous Injection Training Model market size was US$ 653 million in 2025 and is forecast to reach a readjusted size of US$ 1035 million by 2032 with a CAGR of 6.9% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 121
USD 4250.00
(Single User License)
The global Intravenous Injection Training Model market was valued at US$ 653 million in 2025 and is anticipated to reach US$ 1035 million by 2032, at a CAGR of 6.9% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 156
USD 2900.00
(Single User License)
The global market for Intravenous Injection Training Model was estimated to be worth US$ 653 million in 2025 and is projected to reach US$ 1035 million, growing at a CAGR of 6.9% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 180
USD 3950.00
(Single User License)
The global market for Intravenous Injection Training Model was valued at US$ 611 million in the year 2024 and is projected to reach a revised size of US$ 975 million by 2031, growing at a CAGR of 6.9% during the forecast period.
Published Date: 2025-06-28
Pages: 125
USD 2900.00
(Single User License)
The global Intravenous Injection Training Model market is projected to grow from US$ 653 million in 2025 to US$ 975 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.9% during the forecast period.
Published Date: 2025-06-28
Pages: 220
USD 4900.00
(Single User License)
The global market for Intravenous Injection Training Model was estimated to be worth US$ 611 million in 2024 and is forecast to a readjusted size of US$ 975 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published Date: 2025-06-28
Pages: 175
USD 3950.00
(Single User License)
The global Intravenous Injection Training Model market is projected to grow from US$ 653 million in 2025 to US$ 1035 million by 2032, at a CAGR of 6.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-12
Pages: 210
The global Intravenous Injection Training Model market size was US$ 653 million in 2025 and is forecast to reach a readjusted size of US$ 1035 million by 2032 with a CAGR of 6.9% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 121
The global Intravenous Injection Training Model market was valued at US$ 653 million in 2025 and is anticipated to reach US$ 1035 million by 2032, at a CAGR of 6.9% from 2026 to 2032.
Published: 2026-03-12
Pages: 156
The global market for Intravenous Injection Training Model was estimated to be worth US$ 653 million in 2025 and is projected to reach US$ 1035 million, growing at a CAGR of 6.9% from 2026 to 2032.
Published: 2026-03-09
Pages: 180
The global market for Intravenous Injection Training Model was valued at US$ 611 million in the year 2024 and is projected to reach a revised size of US$ 975 million by 2031, growing at a CAGR of 6.9% during the forecast period.
Published: 2025-06-28
Pages: 125
The global Intravenous Injection Training Model market is projected to grow from US$ 653 million in 2025 to US$ 975 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.9% during the forecast period.
Published: 2025-06-28
Pages: 220
The global market for Intravenous Injection Training Model was estimated to be worth US$ 611 million in 2024 and is forecast to a readjusted size of US$ 975 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published: 2025-06-28
Pages: 175
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now